Fosun Pharma (600196): the leading new crown vaccine stocks. On Oct. 15, Fosun Pharma opened with a quote of 50.8 yuan and closed at 50.43 yuan. the share price fell 2.34 percent in five days, with a total market value of 129.247 billion yuan.
Hualan Bio (002007): new crown vaccine leader. On October 15, Hualan Bio opened at 30.08 yuan and closed at 29.8 yuan, down 2.61%. This year's rise fell -40.44%, with a total market capitalization of 54.366 billion yuan.
New crown vaccine concept stocks other are: new Lai should material, Jin Lei shares, JITE biological, unnamed medicine, Guanhao biological, Changhong Meiling, Bohui innovation, Tianhua super clean, Wantai biological, Tai Lin biological, Dongfeng shares, Haiyong Cold Chain, Kangtai biological, Kangdelai and so on.
Characteristics of the disease According to the available case data, the new coronavirus pneumonia to fever, dry cough, malaise, etc. as the main manifestations, a few patients with nasal congestion, runny nose, diarrhea and other upper respiratory and gastrointestinal symptoms. In severe cases, respiratory distress occurs after 1 week, and in severe cases, it rapidly progresses to acute respiratory distress syndrome, septic shock, uncorrectable metabolic acidosis and hemorrhagic coagulation dysfunction and multi-organ failure. It is worth noting that severe and critically ill patients may have low to moderate fever during the course of the disease, or even no obvious fever. Mild patients only show low fever, mild fatigue, etc., without pneumonia. From the current admissions, most patients have a good prognosis, and a few patients are in critical condition. Elderly people and those with chronic underlying diseases have a poorer prognosis. The symptoms in children are relatively mild.
Epidemic Characteristics
WHO Director General Tandace said on March 11, 2020 that the new Crown Pneumonia outbreak has the characteristics of a pandemic. Speaking at his regular press conference in Geneva, Tandesay said the extent and severity of the spread of the outbreak was y worrying, "and we therefore assess that the C. neoformans outbreak has pandemic characteristics."
He said, "We have never before seen a pandemic caused by a coronavirus. We have also never before seen a controlled pandemic." He emphasized that describing the new coronavirus outbreak as a "pandemic" would not change WHO's assessment of the threat, and "it doesn't change what WHO is doing, and it doesn't change what countries should be doing."